130 related articles for article (PubMed ID: 7673733)
21. Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvement.
Mégevand P; Chizzolini C; Chofflon M; Roux-Lombard P; Lalive PH; Picard F
Eur Neurol; 2007; 57(3):166-71. PubMed ID: 17213724
[TBL] [Abstract][Full Text] [Related]
22. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.
Salliot C; Gottenberg JE; Bengoufa D; Desmoulins F; Miceli-Richard C; Mariette X
J Rheumatol; 2007 Nov; 34(11):2253-8. PubMed ID: 17937465
[TBL] [Abstract][Full Text] [Related]
23. Antibodies to AB blood group antigens mimic anti-salivary duct autoantibodies in patients with limited sicca symptoms.
Goldblatt F; Beroukas D; Gillis D; Cavill D; Bradwell A; Rischmueller M; Gordon TP
J Rheumatol; 2000 Oct; 27(10):2382-8. PubMed ID: 11036834
[TBL] [Abstract][Full Text] [Related]
24. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC
J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
Waterman SA; Gordon TP; Rischmueller M
Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
[TBL] [Abstract][Full Text] [Related]
26. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K
J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
[TBL] [Abstract][Full Text] [Related]
27. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
28. Comparative analysis of autoantibodies against a-fodrin in serum, tear fluid, and saliva from patients with Sjögren's syndrome.
Yavuz S; Toker E; Bicakcigil M; Mumcu G; Cakir S
J Rheumatol; 2006 Jul; 33(7):1289-92. PubMed ID: 16821267
[TBL] [Abstract][Full Text] [Related]
29. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease.
Lyons R; Narain S; Nichols C; Satoh M; Reeves WH
Ann N Y Acad Sci; 2005 Jun; 1050():217-28. PubMed ID: 16014537
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome.
Nakamura H; Kawakami A; Eguchi K
Transl Res; 2006 Dec; 148(6):281-8. PubMed ID: 17162248
[TBL] [Abstract][Full Text] [Related]
31. [The immunologic processes of the etiopathogenesis of Sjögren's syndrome].
Oğüt MS; Ergüven S; Irkeç M; Gülmezoğlu E; Ustaçelebi S
Mikrobiyol Bul; 1988 Jan; 22(1):30-5. PubMed ID: 3078788
[TBL] [Abstract][Full Text] [Related]
32. Anti-Ro/SSA and La/SSB antibodies.
Franceschini F; Cavazzana I
Autoimmunity; 2005 Feb; 38(1):55-63. PubMed ID: 15804706
[TBL] [Abstract][Full Text] [Related]
33. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
[TBL] [Abstract][Full Text] [Related]
34. Autoantibodies and the autoimmune diseases.
Josephson AS
Bull N Y Acad Med; 1981 Sep; 57(7):631-7. PubMed ID: 6974027
[No Abstract] [Full Text] [Related]
35. [Some specific antibodies in experimental Sjögren-like disease in rat].
Ishikawa G; Takeda Y
Nihon Rinsho; 1983; 41(1):199-200. PubMed ID: 6601729
[No Abstract] [Full Text] [Related]
36. Short and long-term effects of pandemic unadjuvanted influenza A(H1N1)pdm09 vaccine on clinical manifestations and autoantibody profile in primary Sjögren's syndrome.
Pasoto SG; Ribeiro AC; Viana VS; Leon EP; Bueno C; Neto ML; Precioso AR; Timenetsky Mdo C; Bonfa E
Vaccine; 2013 Apr; 31(14):1793-8. PubMed ID: 23395584
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies in Sjögren's syndrome: clinical presentation and regulatory mechanisms.
Tzioufas AG; Tatouli IP; Moutsopoulos HM
Presse Med; 2012 Sep; 41(9 Pt 2):e451-60. PubMed ID: 22840991
[TBL] [Abstract][Full Text] [Related]
38. Increased risk of multiple myeloma in primary Sjögren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies.
Mofors J; Björk A; Smedby KE; Kvarnström M; Forsblad-d'Elia H; Magnusson-Bucher S; Eriksson P; Mandl T; Baecklund E; Nordmark G; Wahren-Herlenius M
Ann Rheum Dis; 2020 Feb; 79(2):307-308. PubMed ID: 31694814
[No Abstract] [Full Text] [Related]
39. Damage to the endothelium in Sjögren's syndrome: lack of correlation with antinuclear antibody titre and presence of antibodies to SSA or SSB autoantigens.
Blann AD; Wainwright AC; Emery P
Ann Rheum Dis; 1992 Mar; 51(3):389-90. PubMed ID: 1575588
[TBL] [Abstract][Full Text] [Related]
40. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome.
Mariette X; Roux S; Zhang J; Bengoufa D; Lavie F; Zhou T; Kimberly R
Ann Rheum Dis; 2003 Feb; 62(2):168-71. PubMed ID: 12525388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
